{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:48:31Z","timestamp":1793490511174,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009227","name":"Department of Medicine, University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303366\/2015-0"],"award-info":[{"award-number":["303366\/2015-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008645","name":"Terumo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008877","name":"Biosensors International Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/15402-2"],"award-info":[{"award-number":["2015\/15402-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jcmg.2020.10.017","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T15:59:33Z","timestamp":1610639973000},"page":"1164-1173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Empagliflozin Reduces Myocardial Extracellular Volume in Patients With\u00a0Type 2 Diabetes and Coronary\u00a0Artery Disease"],"prefix":"10.1016","volume":"14","author":[{"given":"Tamique","family":"Mason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio R.","family":"Coelho-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajit","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwee","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A.","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"J\u00fcni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Zinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jerosch-Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. David","family":"Mazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2020.10.017_bib1","first-page":"136","article-title":"Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure","volume":"3","author":"Dei Cas","year":"2015","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jcmg.2020.10.017_bib2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0735-1097(03)00166-9","article-title":"Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes","volume":"41","author":"Di Carli","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2020.10.017_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCIMAGING.111.965608","article-title":"Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T1 mapping and subclinical myocardial dysfunction in diabetic patients","volume":"5","author":"Ng","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2020.10.017_bib4","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2003.12.026","article-title":"Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus","volume":"93","author":"Boyer","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2020.10.017_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes\u202f: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jcmg.2020.10.017_bib6","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2020.10.017_bib7","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcmg.2020.10.017_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pcad.2019.07.005","article-title":"Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes","volume":"62","author":"Garg","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jcmg.2020.10.017_bib9","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.119.042375","article-title":"Effect of empagliflozin on left ventricular mass in patients with type 2 diabetes mellitus and coronary artery disease: the EMPA-HEART CardioLink-6 randomized clinical trial","author":"Verma","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2020.10.017_bib10","first-page":"543","article-title":"Direct effects of empagliflozin on extracellular matrix remodelling in human cardiac myofibroblasts: novel translational clues to explain EMPA-REG OUTCOME results","volume":"36","author":"Kang","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jcmg.2020.10.017_bib11","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.amjcard.2019.10.028","article-title":"Potential mechanisms of sodium-glucose co-transporter 2 inhibitor-related cardiovascular benefits","volume":"124","author":"Verma","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2020.10.017_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCIMAGING.112.979815","article-title":"Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease","volume":"6","author":"Coelho-Filho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2020.10.017_bib13","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jcmg.2013.05.013","article-title":"CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy","volume":"6","author":"Neilan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2020.10.017_bib14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcmg.2018.05.012","article-title":"Anthracycline therapy is associated with cardiomyocyte atrophy and preclinical manifestations of heart disease","volume":"11","author":"Ferreira de Souza","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2020.10.017_bib15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jcmg.2012.09.020","article-title":"Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice","volume":"6","author":"Neilan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2020.10.017_bib16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/mrm.10051","article-title":"Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement","volume":"47","author":"Kellman","year":"2002","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jcmg.2020.10.017_bib17","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jcmg.2018.08.021","article-title":"Comparing CMR mapping methods and myocardial patterns toward heart failure outcomes in nonischemic dilated cardiomyopathy","volume":"12","author":"Vita","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2020.10.017_bib18","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1249\/MSS.0000000000002411","article-title":"Left ventricular fibrosis in middle-age athletes and physically active adults","volume":"52","author":"Banks","year":"2020","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jcmg.2020.10.017_bib19","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jcmg.2011.04.015","article-title":"Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient\u2019s sex","volume":"4","author":"Coelho-Filho","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2020.10.017_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12968-014-0069-x","article-title":"Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study","volume":"16","author":"Dabir","year":"2014","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2020.10.017_bib21","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jacc.2017.12.035","article-title":"Reverse myocardial remodeling following valve replacement in patients with aortic stenosis","volume":"71","author":"Treibel","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2020.10.017_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009417","article-title":"Regression of left ventricular mass in athletes undergoing complete detraining is mediated by decrease in intracellular but not extracellular compartments","volume":"12","author":"Swoboda","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2020.10.017_bib23","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.jcmg.2018.11.031","article-title":"Relationship between focal and diffuse fibrosis assessed by CMR and clinical outcomes in heart failure with preserved ejection fraction","volume":"12","author":"Kanagala","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2020.10.017_bib24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1148\/radiol.2018180226","article-title":"Native T1 and extracellular volume measurements by cardiac MRI in healthy adults: a meta-analysis","volume":"290","author":"Gottbrecht","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.jcmg.2020.10.017_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcmg.2010.11.015","article-title":"Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance","volume":"4","author":"Flett","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2020.10.017_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2020.10.017_bib27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/eht193","article-title":"Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission","volume":"35","author":"Wong","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2020.10.017_bib28","article-title":"Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage","volume":"4","author":"Schelbert","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jcmg.2020.10.017_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009535","article-title":"Myocardial extracellular volume fraction adds prognostic information beyond myocardial replacement fibrosis","volume":"12","author":"Yang","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2020.10.017_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jcmg.2019.03.017","article-title":"Extracellular volume associates with outcomes more strongly than native or post-contrast myocardial T1","volume":"13","author":"Treibel","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2020.10.017_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10741-018-9718-8","article-title":"Prognostic value of T1 mapping and extracellular volume fraction in cardiovascular disease: a systematic review and meta-analysis","volume":"23","author":"Zhuang","year":"2018","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jcmg.2020.10.017_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12968-018-0477-4","article-title":"Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction","volume":"20","author":"Roy","year":"2018","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2020.10.017_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.011000","article-title":"Examining the relationship and prognostic implication of diabetic status and extracellular matrix expansion by cardiac magnetic resonance","volume":"13","author":"Khan","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2020.10.017_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/dom.13126","article-title":"Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis","volume":"20","author":"Hallow","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcmg.2020.10.017_bib35","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/ndt\/gfz294","article-title":"The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial","volume":"35","author":"Opingari","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcmg.2020.10.017_bib36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2337\/dc17-1096","article-title":"How does empagliflozin reduce cardiovascular mortality? Insights from a mediation analysis of the EMPA-REG OUTCOME trial","volume":"41","author":"Inzucchi","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcmg.2020.10.017_bib37","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCULATIONAHA.119.044235","article-title":"Effect of empagliflozin on erythropoietin levels, iron stores, and red blood cell morphology in patients with type 2 diabetes mellitus and coronary artery disease","volume":"141","author":"Mazer","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2020.10.017_bib38","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCHEARTFAILURE.113.001036","article-title":"Prognostic value of soluble ST2 in the Valsartan heart failure trial","volume":"7","author":"Anand","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jcmg.2020.10.017_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/CIRCHEARTFAILURE.115.002551","article-title":"Plasma biomarkers reflecting profibrotic processes in heart failure with a preserved ejection fraction","volume":"9","author":"Zile","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jcmg.2020.10.017_bib40","doi-asserted-by":"crossref","first-page":"051","DOI":"10.17352\/2455-2976.000092","article-title":"Targeting metalloproteinases in cardiac remodeling","volume":"6","author":"Doxakis","year":"2019","journal-title":"J\u00a0Cardiovasc Med Cardiol"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X20309396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X20309396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:52:25Z","timestamp":1761846745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X20309396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1936878X20309396"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2020.10.017","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin Reduces Myocardial Extracellular Volume in Patients With\u00a0Type 2 Diabetes and Coronary\u00a0Artery Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2020.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}